Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4 + T cells

Clinical and Experimental Immunology

Volumn 169, Issue 2, 2012, Pages 79-88

  Chen, P ^a,c,d   Baldeviano, G C ^b,e   Ligons, D L ^a,f   Talor, M V ^a   Barin, J G ^a,b   Rose, N R ^a,b   Cihakova, D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c FUDAN UNIVERSITY   (China)

^d NATIONAL EYE INSTITUTE   (United States)

^e California   (Peru)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmunity; Experimental autoimmune myocarditis; IL 6 receptor; Th1; Th17

Indexed keywords

FREUND ADJUVANT; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; MYOSIN; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; DISEASE PREDISPOSITION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT; MICE; MYOCARDITIS; MYOCARDIUM; MYOSINS; SPLEEN; TH17 CELLS;

EID: 84863597179     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04598.x     Document Type: Article

References (44)

1. Li HS, Ligons DL, Rose NR. Genetic complexity of autoimmune myocarditis. Autoimmun Rev 2008; 7:168-73.
2. Guler ML, Ligons DL, Wang Y etal. Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J Immunol 2005; 174:2167-73.
3. Ligons DL, Guler ML, Li HS etal. A locus on chromosome 1 promotes susceptibility of experimental autoimmune myocarditis and lymphocyte cell death. Clin Immunol 2009; 130:74-82.
4. Rose NR, Neumann DA, Herskowitz A etal. Genetics of susceptibility to viral myocarditis in mice. Pathol Immunopathol Res 1988; 7:266-78.
5. Neu N, Rose NR, Beisel KW etal. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139:3630-6.
6. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991; 147:2141-7.
7. Baldeviano GC, Barin JG, Talor MV etal. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 2010; 106:1646-55.
8. Yamashita T, Iwakura T, Matsui K etal. IL-6-mediated Th17 differentiation through RORgammat is essential for the initiation of experimental autoimmune myocarditis. Cardiovasc Res 2011; 91:640-8.
9. Reiner SL. Development in motion: helper T cells at work. Cell 2007; 129:33-6.
10. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337-48.
11. Zhang R, Xing M, Ji X etal. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells. Cytokine 2010; 50:195-203.
12. Take Y, Nakata K, Hashimoto J etal. Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis Rheum 2009; 60:3591-601.
13. Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun 1992; 5 (Suppl. A):123-32.
14. Poffenberger MC, Straka N, El Warry N etal. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis. PLoS ONE 2009; 4:e6207.
15. Eriksson U, Kurrer MO, Schmitz N etal. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 2003; 107:320-5.
16. Institute of Laboratory Animals Resources NRC. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
17. Li HS, Ligons DL, Rose NR etal. Genetic differences in bone marrow-derived lymphoid lineages control susceptibility to experimental autoimmune myocarditis. J Immunol 2008; 180:7480-4.
18. Lenzo JC, Fairweather D, Cull V etal. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. J Mol Cell Cardiol 2002; 34:629-40.
19. Fairweather D, Frisancho-Kiss S, Yusung SA etal. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 2005; 174:261-9.
20. Oyamada A, Ikebe H, Itsumi M etal. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis. J Immunol 2009; 183:7539-46.
21. Havarinasab S, Haggqvist B, Bjorn E etal. Immunosuppressive and autoimmune effects of thimerosal in mice. Toxicol Appl Pharmacol 2005; 204:109-21.
22. Nielsen JB, Hultman P. Mercury-induced autoimmunity in mice. Environ Health Perspect 2002; 110 (Suppl. 5):877-81.
23. Huber SA, Feldman AM, Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res 2006; 99:1109-16.
24. Shi Y, Fukuoka M, Li G etal. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway. Circulation 2010; 121:2624-34.
25. Nishioka T, Shimizu J, Iida R etal. CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol 2006; 176:6586-93.
26. Liu W, Li S, Tian W etal. Immunoregulatory effects of alpha-GalCer in a murine model of autoimmune myocarditis. Exp Mol Pathol 2011; 91:636-42.
27. Wei L, Wei-Min L, Cheng G etal. Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis. Autoimmunity 2006; 39:289-98.
28. Nakae S, Nambu A, Sudo K etal. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173-7.
29. Hofstetter HH, Ibrahim SM, Koczan D etal. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 2005; 237:123-30.
30. Afanasyeva M, Georgakopoulos D, Belardi DF etal. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci USA 2005; 102:180-5.
31. Afanasyeva M, Georgakopoulos D, Fairweather D etal. Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice. Circulation 2004; 110:2910-7.
32. Rangachari M, Mauermann N, Marty RR etal. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006; 203:2009-19.
33. Valaperti A, Marty RR, Kania G etal. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008; 180:2686-95.
34. Sonderegger I, Iezzi G, Maier R etal. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med 2008; 205:2281-94.
35. Jager A, Dardalhon V, Sobel RA etal. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009; 183:7169-77.
36. Fournie GJ, Cautain B, Xystrakis E etal. Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol Rev 2001; 184:145-60.
37. Shah K, Lee WW, Lee SH etal. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010; 12:R53.
38. Assier E, Boissier MC, Dayer JM. Interleukin-6: from identification of the cytokine to development of targeted treatments. Joint Bone Spine 2010; 77:532-6.
39. Bettelli E, Korn T, Oukka M etal. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-7.
40. Laurence A, O'Shea JJ. T(H)-17 differentiation: of mice and men. Nat Immunol 2007; 8:903-5.
41. Wei L, Laurence A, Elias KM etal. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007; 282:34605-10.
42. Harris TJ, Grosso JF, Yen HR etal. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007; 179:4313-7.
43. Chen X, Zhang M, Liao M etal. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med 2010; 181:734-42.
44. Rochman I, Paul WE, Ben-Sasson SZ. IL-6 increases primed cell expansion and survival. J Immunol 2005; 174:4761-7.